« Previous AbstractEvaluation of Key Aroma Compounds in Processed Prawns (Whiteleg Shrimp) by Quantitation and Aroma Recombination Experiments    Next AbstractEvidence for isolation-by-habitat among populations of an epiphytic orchid species on a small oceanic island »

Cureus

Title:		Emerging Approaches to Complement Low-Dose Computerized Tomography for Lung Cancer Screening: A Narrative Review
Author(s):		Maller B; Tanvetyanon T;
Address:		"Internal Medicine, Virginia Commonwealth University, Richmond, USA. Thoracic Oncology, Moffitt Cancer Center, Tampa, USA"
Journal Title:		Cureus
Year:		2022
Volume:		20220726
Issue:		7
Page Number:		e27309 -
DOI:		10.7759/cureus.27309
ISSN/ISBN:		2168-8184 (Print) 2168-8184 (Electronic) 2168-8184 (Linking)
Abstract:		"Lung cancer screening by low-dose computed tomography (LDCT) can save lives. Nevertheless, the test suffers from low accuracy. Improving its accuracy will reduce unnecessary invasive procedures and allow lung cancer treatment to be delivered sooner. This review describes the principles, advantages, and disadvantages of selected emerging modalities potentially useful to improve the accuracy of LDCT. A literature search was conducted using PubMed and Google scholar for relevant publications. We identified four key emerging approaches: radiomics, breath analysis, urine test, and blood test. Radiomics, which uses a computer program to extract various radiological features from radiographic images, holds the potential to improve the accuracy of LDCT. However, to date, there remains no adequately validated system. Breath analysis and urine tests represent a noninvasive and convenient means of screening by detecting substances such as volatile organic compounds associated with lung cancer. However, the results can be confounded by diets, medications, and concurrent medical conditions. Finally, a blood test to screen for protein biomarkers or methylation profiles such as Galleri(R) has high specificity. However, its sensitivity is low, especially for detecting early-stage lung cancer. Furthermore, the cost for mass public use can be significant. Based on our review, blood tests may have potential for future clinical utility. Its high specificity may be useful to rule in a suspicious lung nodule as malignant, so that other additional tests can be omitted. Data from a well-designed clinical trial will be needed to understand the clinical utility of this strategy"
Keywords:		lung cancer lung cancer screening methylation profile radiomics volatolomics;
Notes:		"PubMed-not-MEDLINEMaller, Bradley Tanvetyanon, Tawee eng Review 2022/09/01 Cureus. 2022 Jul 26; 14(7):e27309. doi: 10.7759/cureus.27309. eCollection 2022 Jul"